PharmaShots | Incisive News in 3 Shots

Subscribe Now

Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Reports EP-104GI’s P-Ib/2a (RESOLVE) Study Expansion to Treat Eosinophilic Esophagitis (EoE)

Eupraxia Pharmaceuticals Reports EP-104GI’s P-Ib/2a (RESOLVE) Study Expansion to Treat Eosinophilic Esophagitis (EoE)

May 24, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us